A University of Pittsburgh–led study published November 11, 2026, in Science Translational Medicine analyzed 98,590 participants in the NIH's All of Us Research Program and found that 100% carried at least one genetic variant in 16 pharmacogenes—genes that influence how medications are absorbed, metabolized, transported, or act on the body. The median participant carried nine such variants.